Showing results (131-140 of 319) with videos related to
Sort By:
Pageof 32
Antimicrobial Agents and Chemotherapy|February 19, 2009
Human immunodeficiency virus type 1 isolates with the reverse transcriptase (RT) mutation Q145M retain nucleoside and nonnucleoside RT inhibitor susceptibilityVici Varghese, Yumi Mitsuya, Rajin Shahriar, et al.Bioinformatics (Oxford, England)|March 24, 2009
The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistanceRobert J Gifford, Tommy F Liu, Soo-Yon Rhee, et al.Journal of Clinical Microbiology|August 19, 2016
Evaluation of the Aptima HIV-1 Quant Dx Assay Using Plasma and Dried Blood SpotsMalaya K Sahoo, Vici Varghese, Elizabeth White, et al.AIDS Research and Human Retroviruses|October 22, 2010
HIV-1 integrase sequence variability in antiretroviral naïve patients and in triple-class experienced patients subsequently treated with raltegravirVici Varghese, Tommy F Liu, Soo-Yon Rhee, et al.Physical Review Letters|October 2, 2009
Localized turbulence suppression and increased flow shear near the q=2 surface during internal-transport-barrier formationM W Shafer, G R McKee, M E Austin, et al.The Journal of Infectious Diseases|July 19, 2003
Lack of detectable human immunodeficiency virus type 1 superinfection during 1072 person-years of observationMatthew J Gonzales, Eric Delwart, Soo-Yon Rhee, et al.Plos One|February 27, 2020
Analysis of unusual and signature APOBEC-mutations in HIV-1 pol next-generation sequencesPhilip L Tzou, Sergei L Kosakovsky Pond, Santiago Avila-Rios, et al.Plos One|August 21, 2014
Similar prevalence of low-abundance drug-resistant variants in treatment-naive patients with genotype 1a and 1b hepatitis C virus infections as determined by ultradeep pyrosequencingSeverine Margeridon-Thermet, Sophie Le Pogam, Lewyn Li, et al.Elife|February 17, 2016
More effective drugs lead to harder selective sweeps in the evolution of drug resistance in HIV-1Alison F Feder, Soo-Yon Rhee, Susan P Holmes, et al.Journal of Virological Methods|March 1, 1993
Zidovudine susceptibility testing of human immunodeficiency virus type 1 (HIV) clinical isolatesR W Shafer, M J Kozal, D A Katzenstein, et al.Pageof 32